Terms: = Prostate cancer AND HIST1H4I, MGC24116, 8294, P62805
4 results:
1. Identification of the most significant magnetic resonance imaging (MRI) radiomic features in oncological patients with vertebral bone marrow metastatic disease: a feasibility study.
Filograna L; Lenkowicz J; Cellini F; Dinapoli N; Manfrida S; Magarelli N; Leone A; Colosimo C; Valentini V
Radiol Med; 2019 Jan; 124(1):50-57. PubMed ID: 30191445
[TBL] [Abstract] [Full Text] [Related]
2. Current status of HIFU and cryotherapy in prostate cancer--a review.
Aus G
Eur Urol; 2006 Nov; 50(5):927-34; discussion 934. PubMed ID: 16971038
[TBL] [Abstract] [Full Text] [Related]
3. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer.
Kupelian PA; Reddy CA; Carlson TP; Altsman KA; Willoughby TR
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):904-12. PubMed ID: 12095556
[TBL] [Abstract] [Full Text] [Related]
4. The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy.
Davis BJ; Pisansky TM; Wilson TM; Rothenberg HJ; Pacelli A; Hillman DW; Sargent DJ; Bostwick DG
Cancer; 1999 Jun; 85(12):2630-7. PubMed ID: 10375112
[TBL] [Abstract] [Full Text] [Related]
